What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Internal medicine, Cancer, Surgery, Incidence and Cancer registry.
Søren Friis regularly links together related areas like Oncology in his Internal medicine studies.
His research in the fields of Cancer prevention overlaps with other disciplines such as Repurposing.
His Surgery research incorporates elements of Colorectal cancer, Aspirin, Confounding and Population study.
His study explores the link between Incidence and topics such as Cohort that cross with problems in Epidemiology of cancer and Angiotensin II.
His Cancer registry research includes elements of Gastroenterology, Kidney cancer and Skin cancer.
His most cited work include:
- Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. (266 citations)
- Risk of liver and other types of cancer in patients with cirrhosis : a nationwide cohort study in Denmark (241 citations)
- Cancer risk among statin users: a population-based cohort study. (232 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cancer, Oncology, Surgery and Odds ratio.
His Case-control study, Confidence interval, Cohort study, Cancer registry and Epidemiology study are his primary interests in Internal medicine.
His biological study spans a wide range of topics, including Gynecology, Incidence and Pharmacology, Drug.
His work deals with themes such as Breast cancer, Aspirin, Prostate cancer and Ovarian cancer, which intersect with Oncology.
His study in Surgery is interdisciplinary in nature, drawing from both Capsular contracture and Risk factor.
Søren Friis has researched Odds ratio in several fields, including Statin, Retrospective cohort study and Comorbidity.
He most often published in these fields:
- Internal medicine (71.04%)
- Cancer (31.34%)
- Oncology (34.63%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (71.04%)
- Oncology (34.63%)
- Confidence interval (19.70%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Oncology, Confidence interval, Odds ratio and Cancer.
The various areas that he examines in his Oncology study include Epidemiology, Ovarian cancer, Breast cancer, Prostate cancer and Drug.
His Confidence interval research is multidisciplinary, relying on both Pharmacoepidemiology and Confounding.
Søren Friis interconnects Renal cell carcinoma, Cancer registry, Surgery and Tricyclic in the investigation of issues within Odds ratio.
His research in Surgery intersects with topics in Statin and Incidence.
His research integrates issues of Pharmacology and Cohort in his study of Cancer.
Between 2015 and 2021, his most popular works were:
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 (204 citations)
- Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark (96 citations)
- Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark (96 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Søren Friis mostly deals with Internal medicine, Oncology, Odds ratio, Case-control study and Prostate cancer.
His work in Internal medicine addresses issues such as Surgery, which are connected to fields such as Incidence.
His work carried out in the field of Oncology brings together such families of science as Epidemiology, Tricyclic, Citalopram, Disease and Cohort.
His Odds ratio study integrates concerns from other disciplines, such as Ovarian cancer, Paroxetine, Depression and Sertraline.
His study looks at the intersection of Prostate cancer and topics like Gynecology with Hematology, Prostate neoplasm, Anti-inflammatory, Aspirin and Socioeconomic position.
The Confidence interval study combines topics in areas such as Gastroenterology, Cancer registry and Confounding.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
